Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
To Determine if topical cyclosporine 0.05% BID prevents recurrent inflammation and improves comfort in eyes with pterygia.
Epistemonikos ID: f93c1cb7fe41c4fbe3a5e03b07c5e8c9cd93c1f1
First added on: May 04, 2024